Measuring of quality of life in autoimmune blistering disorders in Poland. Validation of disease – specific Autoimmune Bullous Disease Quality of Life (ABQOL) and the Treatment Autoimmune Bullous Disease Quality of Life (TABQOL) questionnaires-Reference-Cited by-同舟云学术

Measuring of quality of life in autoimmune blistering disorders in Poland. Validation of disease – specific Autoimmune Bullous Disease Quality of Life (ABQOL) and the Treatment Autoimmune Bullous Disease Quality of Life (TABQOL) questionnaires

Published:2017-03 Issue:1 Volume:62 Page:92-96
ISSN:1896-1126
Container-title:Advances in Medical Sciences
language:en
Short-container-title:Advances in Medical Sciences

Author:

Kalinska-Bienias Agnieszka,Jakubowska Beata,Kowalewski Cezary,Murrell Dedee F.,Wozniak Katarzyna

Publisher

Elsevier BV

Subject

General Medicine

Reference22 articles.

1. From epidemiology and genetics to diagnostics, outcome measures, and novel treatments in autoimmune bullous diseases;Ludwig;J Invest Dermatol,2014

2. Quality of life in patients with bullous dermatoses;Sebaratnam;Clin Dermatol,2012

3. Pemphigus and quality of life;Chee;Dermatol Clin,2011

4. Quality of life in patients with pemphigus receiving adjuvant therapy;Paradisi;Clin Exp Dermatol,2012

5. The health impact of pemphigus vulgaris and pemphigus foliaceus assessed using the Medical Outcomes Study 36-item short form health survey questionnaire;Tabolli;Br J Dermatol,2008

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Scoring Criteria for Autoimmune Bullous Diseases: Utility, Merits, and Demerits;Indian Dermatology Online Journal;2024-08-19

2. Trends in disease severity and quality of life outcome measures in pemphigus clinical trials: A scoping review;Skin Health and Disease;2024-07-24

3. Oral Lesions of Immune-Mediated and Autoimmune Diseases: A 12-year Experience at a Single Brazilian Referral Center;Head and Neck Pathology;2024-06-17

4. Impairment of sexual function in patients with pemphigus;Journal of the European Academy of Dermatology and Venereology;2024-03-25

5. Study Design of a Phase 2/3 Randomized Controlled Trial of Dupilumab in Adults with Bullous Pemphigoid: LIBERTY-BP ADEPT;Advances in Therapy;2024-03-05